Differentiating Degenerative from Vascular Dementia with the Help of Optical Coherence Tomography Angiography Biomarkers
- PMID: 35327019
- PMCID: PMC8955832
- DOI: 10.3390/healthcare10030539
Differentiating Degenerative from Vascular Dementia with the Help of Optical Coherence Tomography Angiography Biomarkers
Abstract
Alzheimer's disease and vascular dementia account for the majority of cases of cognitive decline in elderly people. These two main forms of dementia, under which various subtypes fall, are often overlapping and, in some cases, definitive diagnosis may only be possible post-mortem. This has implications for the quality of care and the design of individualized interventions for these patients. Optical coherence tomography angiography (OCTA) is a non-invasive imaging modality used to visualize the retinal layers and vessels which shows encouraging results in the study of various neurological conditions, including dementia. This review aims to succinctly sum up the present state of knowledge and provide critical insight into emerging patterns of OCTA biomarker values in Alzheimer's disease and vascular dementia. According to the current literature, vessel density seems to be a common biomarker for both forms; inner retinal layer thickness might represent a biomarker preferentially affected in degenerative dementia including Alzheimer's, while, in contrast, the outer-layer thickness as a whole justifies attention as a potential vascular dementia biomarker. Radial peripapillary capillary density should also be further studied as a biomarker specifically linked to vascular dementia.
Keywords: Alzheimer’s; biomarkers; neurodegeneration; small vessel disease; vascular cognitive impairment.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Optical coherence tomography angiography as a potential screening tool for cerebral small vessel diseases.Alzheimers Res Ther. 2020 Jun 11;12(1):73. doi: 10.1186/s13195-020-00638-x. Alzheimers Res Ther. 2020. PMID: 32527301 Free PMC article.
-
[The relationship between cognitive impairment and changes in retinal neuroarchitectonics].Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(9):7-13. doi: 10.17116/jnevro20201200917. Zh Nevrol Psikhiatr Im S S Korsakova. 2020. PMID: 33081441 Russian.
-
Role of Optical Coherence Tomography in Identifying Retinal Biomarkers in Frontotemporal Dementia: A Review.Neurol Clin Pract. 2021 Aug;11(4):e516-e523. doi: 10.1212/CPJ.0000000000001041. Neurol Clin Pract. 2021. PMID: 34484950 Free PMC article. Review.
-
The Contribution of Ocular Biomarkers in the Differential Diagnosis of Alzheimer's Disease versus Other Types of Dementia and Future Prospects.J Alzheimers Dis. 2021;80(2):493-504. doi: 10.3233/JAD-201516. J Alzheimers Dis. 2021. PMID: 33554918 Review.
-
Evaluation of optical coherence tomography angiographic findings in Alzheimer's type dementia.Br J Ophthalmol. 2018 Feb;102(2):233-237. doi: 10.1136/bjophthalmol-2017-310476. Epub 2017 Jun 9. Br J Ophthalmol. 2018. PMID: 28600299
Cited by
-
Retinal Vascular Study Using OCTA in Subjects at High Genetic Risk of Developing Alzheimer's Disease and Cardiovascular Risk Factors.J Clin Med. 2022 Jun 6;11(11):3248. doi: 10.3390/jcm11113248. J Clin Med. 2022. PMID: 35683633 Free PMC article.
-
Segmentation of Low-Light Optical Coherence Tomography Angiography Images under the Constraints of Vascular Network Topology.Sensors (Basel). 2024 Jan 25;24(3):774. doi: 10.3390/s24030774. Sensors (Basel). 2024. PMID: 38339491 Free PMC article.
-
DS6, Deformation-Aware Semi-Supervised Learning: Application to Small Vessel Segmentation with Noisy Training Data.J Imaging. 2022 Sep 22;8(10):259. doi: 10.3390/jimaging8100259. J Imaging. 2022. PMID: 36286353 Free PMC article.
-
Detection and Prevention of Mild Cognitive Impairment and Dementia.Healthcare (Basel). 2023 Aug 8;11(16):2232. doi: 10.3390/healthcare11162232. Healthcare (Basel). 2023. PMID: 37628430 Free PMC article.
-
Unlocking the Potential of Vessel Density and the Foveal Avascular Zone in Optical Coherence Tomography Angiography as Biomarkers in Alzheimer's Disease.Healthcare (Basel). 2024 Aug 9;12(16):1589. doi: 10.3390/healthcare12161589. Healthcare (Basel). 2024. PMID: 39201148 Free PMC article. Review.
References
-
- Garre-Olmo J. Epidemiologia de la enfermedad de Alzheimer y otras demencias [Epidemiology of Alzheimer’s disease and other dementias] Rev. Neurol. 2018;66:377–386. - PubMed
Publication types
LinkOut - more resources
Full Text Sources